LOCAL PROVIDER DIRECTORY
Find a dentist
Search by name or specialty, then choose a city and region or enter a ZIP / postal code.
Choose a location to keep your results local.
Local Health Alerts
Medicare Changed Payment for Diabetic Foot Ulcer Skin Substitutes in 2026. What Patients Should Know
Medicare changed how it pays for many skin substitute products used in diabetic foot ulcers in 2026, but it did not broadly stop covering care. Here’s what the change may mean for access, treatment conversations, and when to seek help.
Quartz Countertop Dust Is Triggering Severe Silicosis: Why OSHA’s 2026 Warning Matters
A new federal hazard alert puts fresh attention on a serious worker-health problem in countertop fabrication: inhaling fine silica dust from engineered stone. Here is what the warning says, what California’s cases show, what symptoms matter, and why a new bill in Congress…
How Health Officials Are Trying to Catch Measles Earlier in 2026
Measles detection is getting faster in 2026 through wastewater signals, travel-linked investigations, and county-level tracking. Here is what those tools can do, what they cannot do, and what families should do now.
This Season’s Flu Shot Was Less Effective. What Older Adults Should Do Now
CDC says this season’s flu shot offered lower-than-usual protection in adults, but that does not mean it was useless. For people 65 and older, the key steps now are to stay vaccinated, use an age-preferred shot when possible, and seek antiviral treatment quickly…
FDA’s compounded GLP-1 crackdown: What changed after Ozempic, Wegovy, Mounjaro, and Zepbound shortages ended
With semaglutide and tirzepatide shortages resolved, the FDA is tightening scrutiny of mass-marketed compounded GLP-1s. Here is what changed and what patients should ask now.
FDA warned 30 telehealth companies about compounded GLP-1 ads. What patients should know before buying weight-loss drugs online
The FDA says some telehealth companies used false or misleading marketing for compounded GLP-1 drugs. Here is what that means for patients, how compounded products differ from approved drugs, and what to check before ordering online.
Will Medicare make Ozempic and Rybelsus cheaper? What people with diabetes should know now
The short answer is not yet. Medicare has selected Ozempic, Rybelsus, and Wegovy for drug price negotiation, but the negotiated Medicare price is not scheduled to begin until January 1, 2027. Here is what changed in 2026, why the timeline is confusing, and…
Minnesota’s TMVII outbreak puts a spotlight on sexually associated ringworm: what people should know
A February 11, 2026 Minnesota health advisory reported the largest known U.S. outbreak of TMVII, an emerging ringworm strain linked to intimate skin-to-skin contact. Here is what the rash can look like, why it may be mistaken for other conditions, and why some…
NIH Wants Clinical Trial Volunteers to Get Plain-Language Results. What That Could Mean for Patients
NIH says it is developing a policy framework that could make plain-language study-result summaries more routine for people in NIH-funded clinical research. Here’s what that could mean, what is still only proposed, and what patients should ask before joining a trial.
New U.S. Cholesterol Guidelines Say Prevention May Start Earlier: What Adults in Their 30s Should Know
A new U.S. cholesterol guideline says some adults may need risk discussions earlier, including one-time lipoprotein(a) testing and, in select cases, treatment decisions before age 40.
New JAMA Trial: Spinal Manipulation Alone Did Not Beat Usual Medical Care for Acute Low Back Pain
A large new randomized trial found that spinal manipulation by itself did not significantly outperform guideline-based medical care for pain or disability over 1 year in adults with acute or subacute low back pain at higher risk of long-term problems. Here’s what that…
Colorectal Cancer Is Rising in Younger Adults: What the New 2026 U.S. Numbers Mean
New 2026 U.S. colorectal cancer statistics show a split trend: rates keep falling in many older adults but are rising in younger adults. Here is what that means for symptoms, screening at 45, family history, and why access still matters.
